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Abstract
Hypothalamic and pituitary cells express G protein-coupled adenosine and P2Y receptors and cation-conducting P2X
receptor-channels, suggesting that extracellular ATP and other nucleotides may function as autocrine and/or paracrine
signaling factors in these cells. Consistent with this hypothesis, we show that cultured normal and immortalized pituitary
and hypothalamic cells release ATP under resting conditions. RT-PCR analysis also revealed the presence of transcripts
for ecto-nucleotidase eNTPDase 1Y3 in these cells. These enzymes were functional as documented by degradation of
endogenously released and exogenously added ATP. Blocking the activity of eNTPDases by ARL67156 led to an
increase in ATP release in perifused pituitary cells and inhibition of degradation of extracellularly added ATP.
Furthermore, the addition of apyrase, a soluble ecto-nucleotidase, and the expression of recombinant mouse eNTPDase-2,
enhanced degradation of both endogenously released and exogenously added ATP. The released ATP by resting
hypothalamic cells was sufficient to activate and desensitize high-affinity recombinant P2X receptors, whereas
facilitation of ATP metabolism by the addition of apyrase protected their desensitization. These results indicate that
colocalization of ATP release sites and ecto-nucleotidase activity at the plasma membrane of hypothalamic and pituitary
cells provides an effective mechanism for the operation of nucleotides as extracellular signaling molecules.
Abbreviations: [Ca
2+]i–intracellular calcium concentration; eNTPDase–ecto-nucleoside triphosphate diphosphohydrolase;
P1Rs–adenosine G protein-coupled receptors; P2XRs–purinergic receptor channels; P2YRs–G protein-coupled purinergic
receptors; PRL–prolactin
Introduction
ATP and UTP have to be released by cells to act as
extracellular messengers and are then hydrolyzed by ecto-
nucleotidases, resulting in the formation of the respective
nucleoside and free phosphate. The products of this
hydrolytic cascade, ADP, UDP and adenosine, also act as
extracellular messengers by activating distinct plasma
membrane receptors in numerous excitable and non-
excitable cells [1]. These receptors were termed purinergic
and they belong to two groups: P1 receptors (P1Rs) that are
activated by adenosine and P2 receptors (P2Rs) that
recognize mainly ADP, ATP, UDP and UTP. Two families
compose P2Rs: The ligand-gated channel family (P2XR)
and the G protein-coupled receptor family (P2YR) [2].
Initially, it was believed that single enzymes exist for the
hydrolysis of ATP (ecto-ATPase), ADP (ectoADPase) and
AMP (ecto-5¶-nucleotidase), and that these enzymes are
expressed on the plasma membrane with their catalytic
domain facing the extracellular space [3]. Currently identi-
fied ecto-nucleotidases include members of the ecto-nucle-
oside triphosphate diphosphohydrolase family of enzymes
(eNTPDase) and several other subfamilies of enzymes.
Three out of six known eNTPDases (termed eNTPDase-1,
-2, and -3) are expressed in plasma membrane and, like
P2XRs, are composed of two transmembrane domains,
which place most of the protein extracellularly and its N-
and C-termini intracellularly. These enzymes not only
hydrolyze extracellular ATP and/or ADP to AMP, but also
metabolize other nucleotide tri- and diphosphates, including
UTP and UDP [1].
Normal and immortalized anterior pituitary cells express
A1,A 2A and A2B subtypes of P1 receptors [4Y6]. Several
earlier published reports have also indicated the expression
of P2Rs in anterior pituitary [7Y14]. The first P2 receptor
identified in this tissue was P2Y2R [15]. Recently, we
showed the presence of transcripts for four additional
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anterior pituitary cells and identified the P2Y1R subtype in
lactotroph fraction of cells [16]. Earlier studies revealed the
expression of P2X2aR and its spliced form P2X2bRi n
somatotrophs and gonadotrophs [17, 18], as well as P2X3R,
P2X4R and P2X7R in other pituitary cell types [17, 19]. In
lactotrophs, the P2X4R subtype provides a major pathway
for calcium-influx-dependent signaling and prolactin
(PRL) secretion [16]. Thus, of the 17 known nucleotide
receptors, 12 are probably expressed in the secretory
anterior pituitary. The non-secretory anterior pituitary cells
as well as both neuronal and intermediate lobes of pituitary
also express functional P1/P2 receptors [9, 20Y23]. In that
respect, only the brain expresses more of these receptor
subtypes, indicating the potential relevance of nucleotide-
dependent receptor signaling pathways in pituitary cell
functions.
In contrast to the well-documented expression of P1Rs
and P2Rs in pituitary cells, the knowledge about the
release of purines and pyrimidines by pituitary cells is
limited to two reports. Chen et al. [24] reported that
calcium ionophore A23187 induced release of ATP from
pituitary cells in a concentration- and calcium-dependent
manner. Tomic et al. [14] observed a GnRH-induced
increase in ATP release in perifused pituitary cells. To
our knowledge, the expression and role of ecto-nucleoti-
dases in controlling the extracellular messenger functions
of nucleotides has not been previously established in
pituitary cells. Here we studied the release of ATP in
normal and immortalized pituitary cells as well as in
GnRH-secreting GT1-7 neurons. In addition, we addressed
the efficacy of the released ATP to activate receptors. We
also characterized the capacity of these cells to metabolize
the endogenously released and exogenously added ATP.
The expression of transcripts for eNTPDase 1Y3 was also
analyzed, as well as the inhibition of ATP degradation by
ARL67156, a blocker of these enzymes.
Materials and methods
Cell cultures and treatments
Experiments were performed in anterior pituitary cells
from normal postpubertal female SpragueYDawley rats
obtained from Taconic Farm (Germantown, NY), immor-
talized mouse T3-1 gonadotrophs, mouse AtT20 cortico-
trophs, rat GH3 lacto-somatotrophs, as well as in mouse
GnRH-secreting hypothalamic GT1-7 cells. Pituitary cells
were dispersed as described previously [25] and cultured
as mixed cells in medium 199 containing Earle’s salts
(Invitrogen, Carlsbad, CA), sodium bicarbonate, 10% heat-
inactivated horse serum (Invitrogen), penicillin (100 U/ml)
and streptomycin (100 mg/ml). GT1-7 cells and T3-1
gonadotrophs were cultured in Dulbecco’s modified
Eagle’s medium (DMEM)/Ham’s F12 medium (1:1),
containing 10% (v/v) heat-inactivated fetal bovine serum,
and 100 mg/ml gentamicin (Invitrogen). AtT-20 immortal-
ized corticotrophs cells were cultured in DMEM medium
suppliedwith 10%(v/v)heat-inactivatedfetalbovineserum,
and 100 mg/ml gentamicin. GH3 immortalized pituitary
cells (ATCC, Manassas, VA) were cultured in F12K
Nutrient Mixture with Kaighn’s modification supplemen-
ted with 1.5 g/l sodium bicarbonate, 15% heat-inactivated
horse serum, 2.5% fetal bovine serum, and 100 mg/ml
gentamicin. Cells were treated with ATP (Sigma, St. Louis,
MO), apyrase (grade I, Sigma) and ARL67156 (Tocris,
Ellisville, MO).
Measurements of ATP and PRL
ATP content was monitored using cells in static cultures
and column perifusion experiments. For static culture
experiments, cells were seeded at different densities in
poly-D-lysine-coated 6-well plates and cultured at 37 -C for
24 h. Before assay, cells in each well were washed twice
with 1 ml of ATP-free KrebsYRinger buffer (120 mM
NaCl, 5 mM KCl, 1.26 mM CaCl2, 0.7 mM MgSO4,
10 mM Glucose, and 15 mM HEPES, pH 7.4). Then, cells
were incubated in 1 ml per well of fresh ATP-free or ATP
containing buffer. At the indicated times, samples (õ0.6 ml
of supernatant) were collected and ATP concentration
measured immediately. For perifusion experiments, 5 
10
6 cells were incubated with preswollen cytodex-1 beads
in 60-mm Petri dishes for 24 h. The beads with and without
cells were then transferred to 0.5-ml chambers and
perifused with KrebsYRinger medium containing 0.1%
BSA for 2.5 h at a flow rate of 0.8 ml/min and at 37 -C.
Fractions were collected in 1-min intervals and immedi-
ately assayed for ATP contents using an ATP biolumines-
cent assay kit (Sigma) in TD-20/20 Luminometer (Turner
Designs, Sunnyvale, CA). Calibration curves were con-
structed from measurements of standard solutions, which
were diluted in the same medium as the corresponding
solutions of unknown ATP concentration. Detection limit
of the assay was 0.2 nM. PRL content in culture samples
was determined by radioimmunoassay. Primary antibody
and standard for PRL assay were provided by the National
Pituitary Agency and Dr AF Parlow (Harbor-UCLA
Medical Center, Torrance, CA),
125I-PRL was purchased
from Perkin-Elmer Life Sciences (Boston, MA) and
secondary antibody from Sigma.
Reverse transcriptase-PCR analysis of eNTPDase
expression
Total RNA from rat anterior pituitary and hypothalamic
tissues and cultured cells was extracted using TRIzol
reagent (Invitrogen). After DNase I digestion, 2 mg of total
RNA was reverse-transcribed into first-strand cDNA with
oligo-dT primers and SuperScriptII reverse transcriptase
(Invitrogen). The cDNAs were then amplified with
different eNTPDase isoform-specific primer sets in the
non-conserved region. The oligonucleotide sequences of
primers used for PCR amplification, with GeneBank ac-
cession numbers given in parentheses, are listed as: mouse
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GATCAAAGACAGCAACGC-3¶), antisense (1,583Y1,604
bp, 5¶-TCCTGCTATACTGCCTCTTTCC-3¶); mouse
eNTPDase-2 (AF042811): sense (1,217Y1,235 bp, 5¶-CTG-
CACTGTAGCCATGTTC-3¶), antisense (1,533Y1,554
bp, 5¶-GAAGAGAGATAGCCGGGAGTTG-3¶); mouse
eNTPDase-3 (NM-178676): sense (1,485Y1,504 bp, 5¶-GA-
TCCATCTACCCATACAGC-3¶), antisense (1,684Y1,704 bp,
5¶-TGTGTGGTGTCACTCTGGTGG-3¶); rat eNTPDase-1
(U81285): sense (546Y565 bp, 5¶-GAGCTACCCCTTTGA-
CTTCC-3¶), antisense (669Y690 bp, 5¶-CTGTTTCTGGCT-
GTCTGAGATG-3¶); rat eNTPDase-2 (Y11835): sense
(334Y355 bp, 5¶-CATGCTAGCACACCACTCTACC-3¶),
antisense (519Y539 bp, 5¶-AAGTTCTCCAGCAGGTAG-
TTG-3¶); rat eNTPDase-3 (AJ437217): sense (1,001Y1,023
bp, 5¶-GCCGGAACGAAGCAGAGAAGAAG-3¶), anti-
sense (1,224Y1,245 bp, 5¶-GAAGTCAAACACAGAAGC-
CACC-3¶).
TheamplificationwasconductedinaRobocyclerThermal
Cycler(Stratagene,LaJolla,CA)ina50-ml reaction volume
containing 1 ml of the first-strand cDNA as template, 1 unit
of Taq DNA polymerase (Invitrogen), 0.5 mM concentra-
tion of each primer, 0.2 mM dNTP, and 1  PCR buffer
(2 mM MgCl2, 50 mM KCl, 20 mM TrisYHCl, pH 8.4).
Amplification of DNA templates was initiated by a
denaturation step at 94 -C for 180 s, followed by 35 cycles
of denaturing at 94 -C for 45 s, annealing at 52Y60 -C for
30 s, and extension at 72 -C for 60 s. The reaction was then
terminated by a final extension step at 72 -C for 10 min.
After PCR, a 10-ml aliquot of PCR products was size-
fractionated by electrophoresis in a 1.2% agarose gel and
visualized by ethidium bromide staining. To check the
integrity of RNA preparation, RT-PCR of GAPDH was also
conducted as an internal control using primersGAPDHsense
(5¶-GGCATCCTGGGCTACACTG-3¶) and GAPDH antisense
(5¶-TGAGGTCCACCACCCTGTT-3¶).
DNA constructs and transfection
The coding sequences of the rat P2X2 and P2X3 subunits
were isolated by RT-PCR [26], and subcloned into
biscistronic enhanced green fluorescent protein expression
vector, pIRES2-EGFP (Clontech, Palo Alto, CA) at the
restriction enzyme site of XhoI/PstI for P2X2R and
XhoI/EcoRIf o rP 2 X 3.C h i m e r i cP 2 X 2a/P2X3 subunit
contain extracellular domain from Val
60 to Phe
301 of
P2X3R instead of the native Ile
66YTyr
310 sequence of
P2X2R and was constructed as reported previously [27].
Mouse eNTPDase-2 cDNA clone (MGC clone 5806) was
purchased from Invitrogen and the full-length cDNA
fragment was released by XhoI/EcoRI digestion and then
directionally subcloned into mammalian expression vector,
pcDNA3.1/V5HisA (Invitrogen). Plasmid DNAs for trans-
fection were prepared using a QIAGEN Plasmid Maxi Kit
(Qiagen, Germany). Before the day of transfection, mouse
GT1-7 cells or T3-1 cells were plated on 35 mm culture
dishes or poly-D-Lysine coated 6-well plates. For each dish
of cells, transient transfection of expression constructs was
performed using 1 mg DNA and 7 ml LipofectAMINE
2000 reagent (Invitrogen) in 3 ml serum-free OPTI-MEM.
After 6 h of incubation, transfection mixture was replaced
with normal culture medium. Cells were subjected to
experiments 24Y48 h after transfection.
Calcium measurements
Transfected GT1 cells (100,000 per 35 mm coverslip) were
preloaded with 1 mM Fura-2 acetoxymethyl ester (Fura-2/
AM; Molecular Probe, Eugene, OR) for 60 min at room
temperature in Krebs Ringer medium. After dye loading,
cells were incubated in Krebs Ringer medium and kept in
the dark for at least 30 min before single-cell intracellular
calcium concentration ([Ca
2+]i) measurements. Coverslips
with cells were mounted on the stage of an Axiovert 135
microscope (Carl Zeiss, Oberkochen, Germany) attached to
the Attofluor Digital Fluorescence Microscopy System
(Atto Instruments, Rockville, MD). Cells were stimulated
with ATP and the dynamic changes of [Ca
2+]i were
examined under a 40  oil immersion objective during
exposure to alternating 340- and 380-nm light beams, and
the intensity of light emission at 520 nm was measured.
The ratio of light intensities, F340/F380, which reflects
changes in [Ca
2+]i, was simultaneously followed in several
single cells. EGFP was used as a marker for selection of
cells expressing P2XR. Cells expressing EGFP were
optically detected by an emission signal at 520 nm when
excited by 488-nm ultraviolet light. Experiments were
done in cells with comparable GFP fluorescence intensities
(about 60 arbitrary units) and no repetitive stimulation was
done to avoid the possible impact of desensitization on the
amplitude and pattern of [Ca
2+]i signals.
Results
Release of ATP and PRL
The release of ATP was studied in hypothalamic and
pituitary cells in static culture and in perifusion. In static
cultures of GT1-7, T3-1 and GH3 cells, the replacement
of medium was used as stimulus for ATP release. In
general, the release of ATP was dependent on cell number
and duration of incubation. As shown in Figure 1a, within
5 min after the addition of ATP-free fresh medium to 1 
10
5 GT1-7 cells there was an accumulation of ATP to
about 80 nM ATP, whereas in medium from dishes with
5  10
5 cells the measured ATP concentration was about
160 nM. In medium from dishes without cells there was
practically no measurable ATP. Further incubation of cells
was followed by a progressive decrease in ATP concen-
trations in medium. The release of ATP was not unique for
GT1-7 cells, but was also observed in pituitary cells.
Figure 1b compares the time course of ATP release in
GT1-7, GH3 and T3-1 cells; in all cultures a rapid ATP
release during the first 5 min of incubation was followed
by a progressive decrease in ATP concentrations as their
incubation times were extended (Figure 1b).
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medium could reflect lysis of cells. However, two lines of
evidence argue against this hypothesis. First, the cell
viability and integrity was routinely evaluated by the
addition of trypan blue and no changes were detected
during 60-min incubation. Second, a rapid lysis of cells
should also be reflected on hormone release, but that
was not the case in experiments with GH3 cells. As
shown in Figure 1c, in these cells there was a small PRL
release during the first 5 min of incubation, followed by a
progressive increase in PRL release at extended incubation
times. The dissociation between the time-course of ATP
and hormone accumulation in the medium from GH3
cells indicates that ATP release occurs through either a
pathway other than the exocytotic, or that ATP, but not
PRL, is degraded and therefore a progressive decrease in
extracellular ATP concentrations in static cultures after
replacement of medium reflects the time needed to reach a
balance between ATP release and its degradation by ecto-
nucleotidases.
In additional experiments aimed to further exclude the
possible impact of lysis of cells on ATP release, GT1-7,
T3-1 and GH3 cells were attached on beads and perifused
for 150 min with ATP-free buffer at flow rate of 0.8 ml/
min, prior to sample collection for ATP measurements.
This time was sufficient to stabilize basal hormone
secretion, as illustrated in Figure 2a for PRL release by
perifused GH3 cells. In the same samples there were
measurable levels of ATP, indicating that perifused GH3
cells also release this nucleotide (Figure 2b). Consistent
with the findings in cells in static cultures, ATP was also
released by perifused GT1-7 and T3 cells (Figure 2b).
Again, there was no strict correlation between ATP and
PRL secretory profiles in perifused GH3 cells.
Expression and activity of ecto-nucleotidase
(eNTPDase) 1Y3
To clarify whether the plasma membrane-associated ecto-
nucleotidases are expressed in these cells, RT-PCR analysis
Figure 1. Constitutive release and metabolism of ATP by immortalized
hypothalamic and pituitary cells in static cultures. (a) Dependence of ATP
release on density of cells. ATP concentrations in medium from
hypothalamic GT1-7 cells cultured in 6-well plates at density of 1  10
5
and 5  10
5 cells/well. As controls, media from wells without cells were
used. Dishes were cultured for 24 h, washed twice and kept in 1 ml ATP-
free KrebsYRinger buffer for indicated times at room temperature. At the
end of incubation, media were collected and immediately tested for ATP
concentration. (b) Cell-type specificity of ATP release and degradation.
Cells were cultured at density of 5  10
5 per well. (c) Time-course of PRL
release by GH3 pituitary cells when cultured in experimental conditions
identical to that shown in panel (b). In this and following figures with cells
in static cultures, data points are means T SEM from three experiments,
each performed in sextuplicate determinations. Results for GT1-7 cells in
(a) and (b) were obtained from two different experiments.
Figure 2. Constitutive PRL (a) and ATP (b) release by perifused
hypothalamic and pituitary cell lines. Prior to experiments, cells (5 
10
6) attached on beads were transferred into 0.5-ml chamber and perifused
with ATP-free KrebsYRinger medium for 2.5 h to establish a stable
baseline. During experiments, samples were collected every minute and
immediately tested for ATP and PRL concentrations. Chambers loaded
with beads without cells were used as controls. In this and following
figures with perifused pituitary cells, data points are means T SEM from
three independent experiments.
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plasma membrane-associated eNTPDase subtypes. The
mRNA transcripts of eNTPDase were expressed in mouse
and rat hypothalamic and pituitary cells, as well as in
mouse AtT20 pituitary cells and GT1 hypothalamic cells
(Figure 3a). All three transcripts were also expressed in rat
hypothalamic and pituitary tissues, dispersed pituitary cells
cultured for 24 h, and GH3 cells (Figure 3b). However, we
were unable to observe the presence of specific transcripts
for eNTPDase-1 in mouse T3-1 immortalized gonado-
trophs, whereas the transcripts for the other two isoforms
were present in this cell type (Figure 3a).
In order to estimate the capacity of endogenous ecto-
nucleotidase to degrade ATP, hypothalamic and pituitary
cells were transiently perifused with 10 mM ATP at flow
rate of 0.8 ml/min and the nucleotide concentration was
measured in medium prior, during and after ATP applica-
tion. In media from columns without cells, the measured
levels of ATP were between 8.5 and 10 mM, whereas there
was a substantial decrease of ATP concentrations in media
from columns containing cells. Figure 4 illustrates that in
all cases steady levels of ATP were reached within 2Y3 min
of nucleotide addition. The level of ATP degradation was
dependent on cell type in order: Pituitary cells 9 GH3 9
GT1-7 9 T3-1. These results indicate that eNTPDases
expressed in hypothalamic and pituitary cells are functional
enzymes and provide an effective mechanism for the
control of the extracellular messenger functions of endog-
enously released ATP.
Blockade of ecto-nucleotidase activity
We initially used b-meATP, a slow degradable agonist
[3], to inhibit the endogenous ecto-nucleotidase activity in
hypothalamic and pituitary cells. Unfortunately, this
compound interfered with ATP measurements in our assay.
Therefore, we used ARL67156, a relatively specific blocker
of these enzymes [28]. Pituitary cells were perifused with
the blocker in order to characterize changes in the levels of
both endogenously released and exogenously added ATP.
Inhibition of pituitary ecto-nucleotidases by 50 mM
ARL67156 was sufficient to detect an increase in endog-
enous ATP release. Figure 5a illustrates a progressive
increase in ATP concentrations in medium during ARL67156
Figure 4. Cell-type specificity of extracellular ATP metabolism. Chamber without or with cells (5  10
6 per column) were perifused with
KrebsYRinger buffer at flow rate of 0.8 ml/min. Samples were collected every minute and immediately tested for ATP concentration. Horizontal bars
above traces indicate the duration of ATP application.
Figure 3. Expression of eNTPDase 1Y3 transcripts in hypothalamic and pituitary tissues and cells. For negative controls, PCR was conducted
performing first-strand cDNA synthesis without RT (j). In both panels, DNA markers are shown in the last right lanes. (a) Mouse cell lines. (b) Rat cells
and tissues. GAPDH primers were used as internal control to monitor the quality of RNA preparation. For details, see Materials and methods.
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well as a decrease in medium ATP content after removal of
this blocker. These results confirmed not only that the
endogenously released ATP was not due to cell lysis, but
also that measured ATP concentrations reflect the balance
between de novo released and metabolized nucleotide.
Degradation of extracellularly added ATP by perifused
pituitary cells was also inhibited in a concentration-
dependent manner by ARL67156. However, the majority
of ATP was still degraded in the presence of 50 mM
ARL67156 (Figure 5b). The effect of this compound on
degradation of exogenously added ATP was not only
observed in normal pituitary cells but also in perifused
GH3 cells. In experimental conditions shown in Figure 5c,
about 90% of added ATP (1 mM) was degraded in control
GH3 cells and about 70% in 50 mM ARL67156-treated
cells. Thus, a rapid and dramatic decrease in exogenously
added ATP concentration in perifused cells also reflects a
high activity of endogenous ecto-nucleotidase.
Facilitation of ATP degradation
To enhance degradation of ATP, two experimental ap-
proaches were used: Overexpression of mouse eNTPDase-
2 and the addition of apyrase, a plant soluble ecto-
nucleotidase. eNTPDase-2 was overexpressed in two cell
Figure 5. Effects of ARL67156 on ATP release and metabolism in
perifused pituitary and GH3 cells. (a) Increase in endogenous ATP levels
in pituitary cells perifused with ARL67156. (b) Concentration-dependent
effects of ARL67156 on degradation of exogenously added ATP in
pituitary cells. (c) Effects of ARL67156 on ATP metabolism in perifused
GH3 cells. Gray areas indicate the duration of ARL67156 treatment and
horizontal bars indicate the duration of ATP application.
Figure 6. Facilitation of ATP metabolism by over-expression of
mouse ecto-ATPase eNTPDase-2 (a) and addition of 1 mg/ml apyrase
(b) in T3-1 and GT1-7 cells. Culture medium was washed and replaced
with ATP-free or ATP-containing KrebsYRinger buffer and cells were
incubated for 5 min. Numbers below the bars indicate amounts of ATP
added to the buffer. Asterisks indicate significant differences between
pairs (PG0.01). For details see Materials and methods.
140 M.-L. He et al.lines derived from mouse, T3-1 and GT1-7 cells. Twenty-
four hours after transfection, cells were washed and
samples for ATP measurements were collected 5 min
after replacing the medium. As shown in Figure 6a, left
panel, ATP was released in both vector controls and
eNTPDase-2-expressing T3-1 cells, but the level of ATP
measured in cells overexpressing the enzyme was signif-
icantly lower. In GT1-7 cells over-expressing mouse
eNTPDase type-2, 5-min incubation was sufficient to
metabolize the majority of de novo ATP release (Figure
6a, central panel). The exogenously added ATP (200 nM)
was also rapidly degraded (Figure 6a, right panel). The
addition of apyrase practically masked the endogenously
released ATP from both T3-1 and GT1-7 cells (Figure 6b)
and degraded the majority of extracellularly added ATP
within 5 min of incubation (Figure 6b, right panel).
Desensitization of P2XRs by endogenously released ATP
To examine the biological activity of endogenously re-
leased ATP, we expressed recombinant P2XRs in GT1-7
cells, which do not bear endogenous purinergic receptors
[19]. We purposely selected P2X2aR, P2X2bR, P2X3R and
two chimeras having the ectodomain of P2X3R in the
backbone of P2X2Rs (P2X2a/V
60-F
301X3 and P2X2b/V
60-
F
301X3), because these receptors differ in their EC50s for
ATP: About 50 nM for P2X3R and P2X2/X3R chimera,
which is in the range of ATP concentrations in medium
from cells in resting conditions (Figure 1) and about 3 mM
for P2X2aR and P2X2bR [29]. After replacement of media,
cells were either incubated for 15 and 60 min in the
absence of apyrase, or incubated for 1Y4 h in the presence
of apyrase. After the indicated incubation periods, control
and apyrase-treated cells were stimulated with 10 mM ATP.
Cells treated with apyrase were also stimulated with
conditioned media collected from cultures of GT1-7
neurons incubated for 5 min. Single cell calcium measure-
ments were used to detect the activity of receptors upon
ATP stimulation.
After 60 min of incubation in medium without
apyrase, none of the P2X3R-expressing cells (57 out of
57) showed elevation in [Ca
2+]i in response to ATP
stimulation (Figure 7a, left panel). Practically, 15 min of
incubation in medium without apyrase was sufficient to
abolish responsiveness of the majority of P2X3R-
expressing cells and only in a small fraction of cells a
small amplitude [Ca
2+]i signal was observed (Figure 7a,
central panel). In cultures incubated for 60 min with
apyrase-containing medium, the responsiveness to ATP
was established in all (49 out of 49) cells, clearly
indicating that the endogenously released ATP was
sufficient to activate and desensitize these receptors
(Figure 7a, right panel). Consistent with this conclusion,
in apyrase-treated GT1-7 neurons expressing P2X3R the
addition of conditioned medium from resting cells
triggered response in some (23 out of 41) cells (data not
shown).
Under resting conditions, 60-min incubation also led to
the loss of responsiveness of all P2X2a/V
60-F
301X3 and
P2X2b/V
60-F
301X3-expressing cells (85 out of 85, com-
bined together for both receptors; Figures 7b and c, left
panels). In a substantial fraction of cells incubated for
15 min (24 out of 73 cells) basal [Ca
2+]i was elevated
and the addition of ATP led to further increase in [Ca
2+]i,
followed by a progressive decrease below the initial values
(Figures 7b and c, central panels). In cells bathed in apy-
rase (1 microgram/ml)-containing medium for 4 h, ATP
induced typical a pattern of calcium signals, determined by
the rates of activation and desensitization of receptors
(Figures 7b and c, right panels). In apyrase-pretreated cells,
the addition of conditioned medium collected from resting
cells elevated [Ca
2+]i in 21 out of 46 cells, confirming that
Figure 7. Desensitization of recombinant rat P2XRs expressed in GT1-7
cells by endogenous ATP. Left column: The lack of effects of exogenously
added ATP on activation of P2X3R (a) and chimeric receptors (b and c),
but not P2X2Rs (d and e), in cells cultured in medium without apyrase, a
soluble ecto-ATPase, for 60 min. Central column: Patterns of ATP-
induced [Ca
2+]i signaling by parental receptors and their chimeras in cells
incubated in medium without apyrase for 15 min. Right column: Patterns
of ATP-induced [Ca
2+]i signaling by parental and chimeric receptors in
cells incubated in medium containing apyrase. In dishes with parental
receptors the enzyme was present for 1 h, whereas in those with cells
expressing chimeras apyrase was present at least 4 h. Traces shown are
mean values from at least 10 EGFP-positive cells in one from three to five
dishes. For details on expression of P2XRs, see Materials and methods.
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the threshold level for activation of these receptors (data
not shown).
In contrast to P2X3R and chimeric receptors, all
P2X2aR and P2X2bR-expressing cells responded to ATP
stimulation independently of the duration of resting period
and presence/absence of apyrase (Figures 7d and e),
indicating that in these experimental conditions the level
of endogenously released ATP is below the threshold dose
required for activation and desensitization of these two
receptors. In accordance with this, conditioned media from
resting cells triggered [Ca
2+]i signals in none of the P2X2aR
and P2X2bR-expressing cells (35 out of 35; data not
shown). All together, these results indicate that endoge-
nously released ATP is biologically active and that in vitro
released ATP levels are sufficient to activate and desensi-
tize high affinity receptors.
Discussion
The presence of phospholipase C-coupled P2YRs was
initially observed in a mixed population of sheep pituitary
cells [12, 13]. Subsequent studies showed that rat pituitary
cells also express P2YRs; their activation by ATP is
associated with an elevation in [Ca
2+]i due to release of
calcium from intracellular stores [10, 11, 30]. Molecular
cloning and functional characterization of rat P2YRs in the
pituitary revealed the expression of P2Y2Rw i t ht h e
pharmacological profile resembling the one observed in
sheep pituitary cells [15]. Additional studies have sug-
gested the presence of P2XRs in normal and immortalized
pituitary cells [8, 9, 14]. Initially, the mRNAs for P2X2aR
and its spliced form, P2X2bR, were found in pituitary cells
and functional receptors were identified in gonadotrophs
and somatotrophs [18, 19, 31, 32]. This was followed by
discovery of transcripts for P2X3R, P2X4R, and P2X7Ri n
pituitary cells [17], and the finding that lactotrophs express
P2X4R, which plays a major role in control of calcium-
influx-dependent PRL release [16]. Transcripts for P2Y1R,
P2Y4R, and P2Y6R have also been detected in anterior
pituitary cells and functional P2Y1R were identified in
lactotrophs [16]. Adenosine also operates as an extracellu-
lar messenger in anterior pituitary cells by activating A1,
A2A and A2B receptors [5]. Such a complex expression
pattern of P1Rs and P2Rs is consistent with the hypothesis
that purinergic receptors play important roles in control of
anterior pituitary functions.
The physiological sources of extracellular nucleotides
required for activation of these receptors in pituitary cells
remains largely uncharacterized. Here we show that ATP is
releasedbynormalandimmortalizedpituitarycells,aswellas
byGT1-7cells,atrestingconditions.Threelinesofevidence
arguesagainstthehypothesisthatlysisofcellsunderliesATP
release.ArapidincreaseinATPreleaseinGH3 cells in static
cultures after medium replacement was not accompanied
with rapid PRL release. ATP was also released by pituitary
cells perifused for 2.5 h at flow rate of 0.8 ml/min. Finally,
there is a gradual and transient increase in the rate of ATP
release in the presence of ARL67156. In general, neurons,
neuroendocrine cells and platelets release ATP by calcium-
controlled exocytosis of nucleotides stored within synap-
tic vesicles or dense core granules [33]. Since anterior
pituitary cells secrete hormones by exocytotic pathway, it
is reasonable to postulate that ATP is also released through
the same pathway. However, in this study we were unable
to observe a correlation between ATP and PRL release in
resting GH3 cells. It is well established that purinergic
receptors are also expressed in cell types that do not secrete
by exocytosis [2]. This suggests that ATP could also be
released by another mechanism, but the nature of this
pathway is not known at the present time [34]. Both
secretory and non-secretory ATP release pathways are
probably operative in human astrocytes [35], whereas
further studies are needed to clarify which mechanism is
responsible for ATP release in pituitary cells.
Although the action of ATP as an autocrine/paracrine
factor is critically dependent on its rapid metabolism by
ecto-nucleotidases,the expressionandroleoftheseenzymes
in control of nucleotide-dependent signaling in pituitary
cells was not previously addressed. Here we provide
evidence that these enzymes are expressed and operative
in hypothalamic and pituitary cells. First, we show that
transcripts for three plasma membrane-located eNTPDases
are expressed in hypothalamic and pituitary tissues, cultured
pituitary cells and immortalized lacto-somatotrophs,
corticotrophs, gonadotrophs and GnRH-secreting cells. We
also show that these enzymes are capable of degrading both
endogenously released and exogenously added ATP.
Depending on the cell type, 5  10
6 cells perifused at flow
rate of 0.8 ml/min were able to degrade 27%Y70% of
extracellularly added ATP. Finally, we show the impact of
inhibition of these enzymes on ATP degradation. Thus, the
ATP concentration measured in our experimental condi-
tions reflects the equilibrium between the rate of ATP
release and the rate of ATP hydrolysis by endogenously
expressed ecto-nucleotidases.
In general, there are three possible ways to attenuate the
endogenous ecto-nucleotidase activity in a particular cell
type: Removal of calcium, addition of slow-metabolizing
agonists and application of ecto-nucleotidase-specific
inhibitors. The activity of these enzymes depends on
extracellular calcium concentration [3]. However, calcium
is also required for activation of exocytosis, which in
lactotrophs and somatotrophs occurs in the absence of
agonist stimulation and is driven by spontaneous voltage-
gated calcium influx [36]. Thus, removal of calcium also
affects both hormone secretion and the associated ATP co-
secretion. The ecto-nucleotidases are also blockable by b-
methylene ATP [3], but this slow metabolizing agonist
interferes with ATP measurements in our assay, which is
not the case for ARL67156, a specific inhibitor for some
ecto-nucleotidases. This compound significantly and re-
versibly inhibited ATP degradation in normal and immor-
talized pituitary cells. Inhibition of metabolism of ATP
by ARL67156 clearly indicates that the released ATP is
not due to cell lysis or loss of plasma membrane integrity,
but reflects an active process. However, the potency of
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enough, which limits the utility of this blocker for further
investigations on the rate and mechanism of ATP release
by pituitary cells.
One may speculate that the endogenously released
ATP by hypothalamic and pituitary cells is not biolog-
ically active or it is below the threshold required for
activation of P2Rs. To test this hypothesis, we expressed
P2X2R and P2X3R in GT1-7 cells. At the density of 1 
10
5 cells per 35 mm coverslip, our results indicate that the
endogenously released ATP was sufficient to desensitize
P2X3R and P2X2/X3 chimeras, but not P2X2R. This was
further supported by the finding that the ATP concen-
trations in conditioned culture medium are comparable to
the EC50 values required for activation of P2X3R. Thus, the
endogenously released ATP is biologically active and is
able to stimulate at least a fraction of P2R subtypes
expressed in these cells. Certainly, these in vitro con-
ditions should not fairly reflect the in vivo situation, where
tissue ATP concentration reflects a balance between rates
of release, hydrolysis and dilution into intercellular
compartment.
Limited information exists about the roles of P2XR in
hypothalamic and pituitary cells and the integration of
P1Rs in signaling through ecto-nucleotidase-dependent
conversion of ATP to adenosine. Stimulation of LH and
PRL release by addition of ATP has been previously shown
[7, 14, 16]. We may also speculate that the actions of ATP
as an autocrine and paracrine factor in pituitary cells,
which express numerous P2YRs and P2XRs, provide a
potential mechanism for a progressive amplification of
ATP secretory response and a dose-dependent activation of
specific receptors. Although gap junction channels contrib-
ute to synchronized calcium signaling among pituitary cells
[37], it is also reasonable to speculate that extracellular
ATP plays a role in intercellular propagation of calcium
waves between secretory and non-secretory anterior pitu-
itary cell types. Finally, the finding that GT1-7 neurons
release ATP but do not express P2Rs may indicate that in
vivo GnRH neurons influence other P2R-expressing neu-
rons through ATP-mediated synaptic transmission rather
than by GnRH.
In summary, we show that ATP is released by
hypothalamic and pituitary cells and is metabolized by
ecto-nucleotidases. The release of ATP is not due to lysis
of cells but reflects an active process. Moreover, endoge-
nously released ATP is biologically active and its in vitro
levels are sufficient to stimulate and desensitize P2XRs,
according to their ligand affinity. The signaling functions
of ATP are inhibited by ARL67156-sensitive ecto-nucleo-
tidases. These results are consistent with the hypothesis
that in pituitary cells P2Rs and ecto-nucleotidases compete
for a limited pool of endogenously released ATP. The ecto-
nucleotide cascade not only terminates the extracellular
messenger functions of ATP but also provides a pathway
for the generation of ADP and adenosine, which in
pituitary cells may activate some P2YRs and P1Rs,
respectively. Finally, these enzymes may build up a
mechanism for the control of ligand-dependent desensiti-
zation of purinergic receptors within the pituitary, which
may be relevant to the homeostasis of the gland.
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